Forty state legislators have sent a letter to the Group Insurance Commission board warning about the public health risks involved with eliminating coverage for GLP-1 weight-loss drugs for obesity — a move that they predict could drive up future hospitalizations and lead to an increase in health care costs as the health of public employees […]
